Literature DB >> 22223122

Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease.

Helen Michelakakis1, Georgia Xiromerisiou, Efthimios Dardiotis, Maria Bozi, Demetrios Vassilatis, Persa-Maria Kountra, Gianna Patramani, Marina Moraitou, Dimitra Papadimitriou, Eleftherios Stamboulis, Leonidas Stefanis, Elias Zintzaras, Georgios M Hadjigeorgiou.   

Abstract

Lysosomal protein 2 (LIMP2), the product of the scavenger receptor class B member 2 (SCARB2) gene, is a ubiquitously expressed transmembrane protein that is the mannose-6-phosphate-independent receptor for glucocerebrosidase (β-GCase); a deficiency in this protein causes Gaucher disease. Several studies have shown a link between mutations in the β-GCase gene and diseases characterized clinically by Parkinsonism and by the presence of Lewy body-related pathology. We hypothesized that genetic variants in the SCARB2 gene could be risk factors for Parkinson's disease (PD). A candidate-gene study of 347 Greek patients with sporadic PD and 329 healthy controls was conducted to investigate the association between 5 polymorphisms in the SCARB2 gene (rs6824953, rs6825004, rs4241591, rs9991821, and rs17234715) and the development of PD. The single-locus analysis for the 5 polymorphisms revealed an association only for the rs6825004 polymorphism: the generalized odds ratio (OR(G) ) was 0.68 (95% confidence interval [CI], 0.51-0.90), and the OR for the allelic test was OR = 0.71 (95% CI, 0.56-0.90). Haplotype analysis showed an association for the GCGGT haplotype (P < .01). Our study supports a genetic contribution of the SCARB2 locus to PD; future studies in larger cohorts are necessary to verify this finding.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22223122     DOI: 10.1002/mds.24886

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

Review 1.  Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.

Authors:  Ashley Gonzalez; Mark Valeiras; Ellen Sidransky; Nahid Tayebi
Journal:  Mol Genet Metab       Date:  2013-12-11       Impact factor: 4.797

Review 2.  Lysosome trafficking and signaling in health and neurodegenerative diseases.

Authors:  Pearl P Y Lie; Ralph A Nixon
Journal:  Neurobiol Dis       Date:  2018-05-30       Impact factor: 5.996

Review 3.  GBA-Associated Parkinson's Disease and Other Synucleinopathies.

Authors:  Ziv Gan-Or; Christopher Liong; Roy N Alcalay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-08       Impact factor: 5.081

4.  Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes.

Authors:  Carolina Courage; Karen L Oliver; Eon Joo Park; Jillian M Cameron; Kariona A Grabińska; Mikko Muona; Laura Canafoglia; Antonio Gambardella; Edith Said; Zaid Afawi; Betul Baykan; Christian Brandt; Carlo di Bonaventura; Hui Bein Chew; Chiara Criscuolo; Leanne M Dibbens; Barbara Castellotti; Patrizia Riguzzi; Angelo Labate; Alessandro Filla; Anna T Giallonardo; Geza Berecki; Christopher B Jackson; Tarja Joensuu; John A Damiano; Sara Kivity; Amos Korczyn; Aarno Palotie; Pasquale Striano; Davide Uccellini; Loretta Giuliano; Eva Andermann; Ingrid E Scheffer; Roberto Michelucci; Melanie Bahlo; Silvana Franceschetti; William C Sessa; Samuel F Berkovic; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2021-04-01       Impact factor: 11.025

Review 5.  Exploring genetic modifiers of Gaucher disease: The next horizon.

Authors:  Brad A Davidson; Shahzeb Hassan; Eric Joshua Garcia; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2018-09-11       Impact factor: 4.878

6.  Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data.

Authors:  Emerson Maniwang; Nahid Tayebi; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2013-01-29       Impact factor: 4.797

7.  Association between rs6812193 polymorphism and sporadic Parkinson's disease susceptibility.

Authors:  Qiang Huo; Tao Li; Peiqing Zhao; Lianqing Wang
Journal:  Neurol Sci       Date:  2015-03-29       Impact factor: 3.307

Review 8.  Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease.

Authors:  Iva Stojkovska; Dimitri Krainc; Joseph R Mazzulli
Journal:  Cell Tissue Res       Date:  2017-10-24       Impact factor: 5.249

9.  No association of FAM47E rs6812193, SCARB2 rs6825004 and STX1B rs4889603 polymorphisms with Parkinson's disease in a Chinese Han population.

Authors:  YongPing Chen; XiaoQin Yuan; Bei Cao; QianQian Wei; RuWei Ou; Jing Yang; XuePing Chen; Bi Zhao; Wei Song; Ying Wu; HuiFang Shang
Journal:  J Neural Transm (Vienna)       Date:  2015-07-30       Impact factor: 3.575

Review 10.  Glucocerebrosidase is shaking up the synucleinopathies.

Authors:  Marina Siebert; Ellen Sidransky; Wendy Westbroek
Journal:  Brain       Date:  2014-02-14       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.